Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 May 1;63(1):31–33. doi: 10.1097/QAI.0b013e3182874d41

Figure 1.

Figure 1

Correlation between ADCVI assays run on separate days with different effector cell donors. Plasma samples were tested against CEM.NKR-CCR5 cells infected with either HIV-1BS208.B1 (A) or HIV-1Q23XhoΔXho (B) on two separate occasions and with different effector cell donors. Data are shown as logit-transformations of mean % virus inhibition. ADCVI activity for each subject (represented by a unique symbol and line) with each effector cell donor is also shown (C). Each plasma sample was run in triplicate each of the four assays depicted.

HHS Vulnerability Disclosure